PRS46 - Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden. - Wlodarczyk, J; Hunsche, E; Silberberg, B; Kemp, D; Anell, B; Corcoran, K; Minacori, R; Stevenson, M; Beaudet, A (Value in Health, 2016)